Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons

Journal of Neuroscience

Volumn 33, Issue 43, 2013, Pages 17095-17107

  Golden, Judith P ^a   DeMaro III, Joseph A ^a   Knoten, Amanda ^a   Hoshi, Masato ^a   Pehek, Elizabeth ^b,c   Johnson Jr , Eugene M ^a   Gereau IV, Robert W ^a   Jain, Sanjay ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3, 4 DIHYDROXYPHENYLACETIC ACID; CARBIDOPA; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; HOMOVANILLIC ACID; LEVODOPA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EPIFLUORESCENCE MICROSCOPY; FEMALE; GAIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; LOCOMOTION; MALE; MOUSE; MUSCLE WEAKNESS; NEWBORN; NONHUMAN; OPEN FIELD BEHAVIOR; PARKINSON DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ROTAROD TEST; SENSORIMOTOR FUNCTION;

ANIMALS; DIPHTHERIA TOXIN; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINERGIC NEURONS; GAIT; HALOPERIDOL; LEVODOPA; MESENCEPHALON; MICE; MICE, TRANSGENIC; MUTATION;

EID: 84886890717     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0890-13.2013     Document Type: Article

References (64)

1. Archer T., Danysz W, Fredriksson A, Jonsson G, Luthman J, Sundström E, Teiling A (1988) Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning. Pharmacology, biochemistry, and behavior 31:357-364. CrossRef Medline
2. Bakos J., Duncko R, Makatsori A, Pirnik Z, Kiss A, Jezova D (2004) Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring. Ann N Y Acad Sci 1018:281-287. CrossRef Medline
3. Barlow B.K., Cory-Slechta DA, Richfield EK, Thiruchelvam M (2007) The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. Reprod Toxicol 23: 457-470. CrossRef Medline
4. Blandini F., Armentero MT (2012) Animal models of Parkinson's disease. FEBS J 279:1156-1166. CrossRef Medline
5. Bové J., Perier C (2012) Neurotoxin-based models of Parkinson's disease. Neuroscience 211:51-76. CrossRef Medline
6. Breese G.R., TraylorTD (1971) Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br J Pharmacol 42:88-99. CrossRef Medline
7. Breese G.R., Traylor TD (1972) Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine. Br J Pharmacol 44:210-222. CrossRef Medline
8. Breese G.R., Napier TC, Mueller RA (1985) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234:447-455. Medline
9. Breese G.R., Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL (2005) The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Brain Res Rev 48:57-73. CrossRef Medline
10. Brotchie J., Fitzer-Attas C (2009) Mechanisms compensating for dopamine loss in early Parkinson disease. Neurology 72:S32-S38. CrossRef Medline
11. Bruno J.P., Stricker EM, Zigmond MJ (1985) Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav Neurosci 99:771-775. CrossRef Medline
12. Byler S.L., Boehm GW, Karp JD, Kohman RA, Tarr AJ, Schallert T, Barth TM (2009) Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57BL/6J mice. Behav Brain Res 198:434-439. CrossRef Medline
13. Cano-de-la-Cuerda R, Pérez-de-Heredia M, Miangolarra-Page JC, Muñoz-Hellín E., Fernández-de-Las-Peñas C (2010) Is there muscular weakness in Parkinson's disease? Am J Phys Med Rehabil 89:70-76. CrossRef Medline
14. Carvey P.M., Chang Q, Lipton JW, Ling Z (2003) Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci 8:s826-837. CrossRef Medline
15. Castañeda E., Whishaw IQ, Lermer L, Robinson TE (1990) Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res 508: 30-39. CrossRef Medline
16. Cerruti C., Walther DM, Kuhar MJ, Uhl GR (1993) Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res Mol Brain Res 18:181-186. CrossRef Medline
17. Collier T.J., Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR Jr, Kordower J.H. 2007 Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates; diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis 26:56-65. Medline
18. Collier T.J., Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nat Rev Neurosci 12:359-366. CrossRef Medline
19. Da Silva Costa V, Duchatelle P, Boulouard M, Dauphin F (2009) Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse. Neuropsychopharmacology 34:488-500. CrossRef Medline
20. Dauer W., Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909. CrossRef Medline
21. Duncan G.E., Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR (1987) Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J Pharmacol Exp Ther 243:1027-1034. Medline
22. Dunnett S.B., Lelos M (2010) Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease. Prog Brain Res 184: 35-51. CrossRef Medline
23. Erinoff L., MacPhail RC, Heller A, Seiden LS (1979) Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res 164: 195-205. CrossRef Medline
24. Erinoff L., Kelly PH, Basura M, Snodgrass SR (1984) Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found. Pharmacol Biochem Behav 20:707-713. CrossRef Medline
25. Franklin B.J., Paxinos GT (1997) The mouse brain in stereotaxic coordinates. Academic: New York.
26. Fujita M., Shimada S, Nishimura T, Uhl GR, Tohyama M (1993) Ontogeny of dopamine transporter mRNA expression in the rat brain. Brain Res Mol Brain Res 19:222-226. CrossRef Medline
27. Gage F.H., Dunnett SB, Björklund A (1984) Spatial learning and motor deficits in aged rats. Neurobiol Aging 5:43-48. CrossRef Medline
28. Giros B., Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612. CrossRef Medline
29. Gundersen H.J., Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard J.R., Pakkenberg B, Sørensen FB, Vesterby A (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379-394. CrossRef Medline
30. Hickey P., Stacy M (2012) Adenosine A2A antagonists in Parkinson's disease: what's next? Curr Neurol Neurosci Rep 12:376-385. CrossRef Medline
31. Jain S., Golden JP, Wozniak D, Pehek E, Johnson EM Jr, Milbrandt J (2006) RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J Neurosci 26:11230-11238. CrossRef Medline
32. Kobayashi M., Iaccarino C, Saiardi A, Heidt V, Bozzi Y, Picetti R, Vitale C, Westphal H., Drago J, Borrelli E (2004) Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice. Proc Natl Acad Sci U S A 101:11465-11470. CrossRef Medline
33. Li Z.S., Pham TD, Tamir H, Chen JJ, Gershon MD (2004) Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J Neurosci 24:1330-1339. CrossRef Medline
34. Ling Z., Gayle DA, Ma SY, Lipton JW, Tong CW, Hong JS, CarveyPM (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disorder 17:116-124. CrossRef Medline
35. Ling Z., Zhu Y, Tong CW, Snyder JA, Lipton JW, CarveyPM (2009) Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Exp Neurol 216:312-320. CrossRef Medline
36. Livak K.J., Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25:402-408. CrossRef Medline
37. Marshall J.F., Richardson JS, Teitelbaum P (1974) Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J Comp Physiol Psychol 87: 808-830. CrossRef Medline
38. Meredith G.E., Kang UJ (2006) Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord 21:1595-1606. CrossRef Medline
39. Mohajjel Nayebi AA, Sheidaei H (2010) Buspirone improves haloperidolinduced Parkinson disease in mice through 5-HT1A receptors. DARU 18:41-45. Medline
40. Montana M.C., Cavallone LF, Stubbert KK, Stefanescu AD, Kharasch ED, Gereau R.W. 4th (2009) The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine. J Pharmacol Exp Ther 330:834-843. CrossRef Medline
41. Muthian G., Mackey V, King J, CharltonCG (2010) Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Neuroscience 169:1085-1093. CrossRef Medline
42. Ovadia A., Zhang Z, GashDM (1995) Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 16:931-937. CrossRef Medline
43. Pehek E.A., Crock R, Yamamoto BK (1992) Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions. Synapse 10:317-325. CrossRef Medline
44. Peng J., Peng L, Stevenson FF, Doctrow SR, Andersen JK (2007) Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci 27:6914-6922. CrossRef Medline
45. Ponce F.A., Lozano AM (2010) Deep brain stimulation state of the art and novel stimulation targets. Prog Brain Res 184:311-324. CrossRef Medline
46. Reader T.A., Dewar KM (1999) Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. Neurochem Int 34:1-21. CrossRef Medline
47. Shaywitz B.A., Yager RD, Klopper JH (1976) Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191:305-308. CrossRef Medline
48. Smith R.D., Cooper BR, Breese GR (1973) Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine. J Pharmacol Exp Ther 185: 609-619. Medline
49. Storch A., Ludolph AC, Schwarz J (2004) Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm 111:1267-1286. CrossRef Medline
50. Taylor M.D., Vancura R, Patterson CL, Williams JM, Riekhof JT, Wright DE (2001) Postnatal regulation of limb proprioception by muscle-derived neurotrophin-3. J Comp Neurol 432:244-258. CrossRef Medline
51. Taylor T.N., Greene JG, MillerGW (2010) Behavioral phenotyping of mouse models of Parkinson's disease. Behav Brain Res 211:1-10. CrossRef Medline
52. Thiruchelvam M., McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte D.A., Cory-Slechta DA (2003) Age-related irreversible progres-sive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 18:589-600. CrossRef Medline
53. Tillerson J.L., Caudle WM, Reverón ME, Miller GW (2002) Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol 178:80-90. CrossRef Medline
54. Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107-110. CrossRef Medline
55. Ungerstedt U (1971) Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:95-122. Medline
56. Weihmuller F.B., Bruno JP (1989) Drinking behavior and motor function in rat pups depleted of brain dopamine during development. Dev Psychobiol 22:101-113. CrossRef Medline
57. Whishaw I.Q., Funk DR, Hawryluk SJ, Karbashewski ED (1987) Absence of sparing of spatial navigation, skilled forelimb and tongue use and limb posture in the rat after neonatal dopamine depletion. Physiol Behav 40: 247-253. CrossRef Medline
58. Wu S., Wu Y, Capecchi MR (2006) Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo. Development 133:581-590. CrossRef Medline
59. Zhou Q.Y., Palmiter RD (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209. CrossRef Medline
60. Zhuang X., Masson J, Gingrich JA, Rayport S, Hen R (2005) Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods 143:27-32. CrossRef Medline
61. Zigmond M.J., Stricker EM (1973) Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science 182:717-720. CrossRef Medline
62. Zigmond M.J., Stricker EM (1980) Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion. Experientia 36: 436-438. CrossRef Medline
63. Zigmond M.J., Acheson AL, Stachowiak MK, Stricker EM (1984) Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch Neurol 41:856-861. CrossRef Medline
64. Zigmond M.J., Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290-296. CrossRef Medline